Northwire Canada EditionThursday, October 15, 2026
Sign inSubscribe
Northwire
⌕
GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4% GOLD 4107.90 −1.7% SILVER 55.88 −6.1% COPPER 6.62 −1.6% OIL 95.09 +1.0% PALLADIUM 1096.50 −2.7% CIA 2.64 −0.4% BTO 7.09 −4.3% MCI 0.155 +0.0% CAN 0.065 +0.0% BLDS 0.335 +8.1% SAO 0.050 +0.0% SF 0.315 +0.0% BEA 0.055 −15.4% BMM 3.90 +11.1% AUGC 0.295 −13.2% MFG 3.34 −3.8% CDE 21.33 −7.7% CYG 0.160 −5.9% RSMX 0.100 −4.8% TUF 0.830 −5.7% GPG 0.285 −3.4%
Financings Routine +

Restart Life Sciences Closes Dedicated Purchase Order Financing Private Placement; CEO Subscribes for 50% of Offering

Restart Life Closes Financing as Revenue Growth Fails to Halt Stock Erosion

By The Northwire Desk — AI Analysis May 21, 2026 · 06:01 HEAL · 0.095 Restart Life Sciences Corp.
Executive Summary
  • Restart Life Sciences Corp. closed a non-brokered private placement on May 21, 2026, raising CAD $100,000.08.
  • The offering consisted of 833,334 units at CAD $0.12 per unit, each containing one common share and one warrant.
  • Warrants are exercisable at CAD $0.15 for a period of two years from closing.
  • CEO Steve Loutskou subscribed to 50% of the offering (416,666 units), investing approximately CAD $50,000.
  • Proceeds are designated as upfront working capital for Holy Crap Foods Inc. to manufacture and fulfill pending wholesale and e-commerce purchase orders.
  • The structure utilizes a "rapid-recycling" model intended to bypass retail collection lag times common in the CPG industry (60 to 180 days).
  • No finder's fees were paid, and securities are subject to a four-month-and-one-day hold period expiring September 21, 2026.
Material Impact
  • The news is classified as Routine - Positive because it represents the closing of a financing previously announced on May 8, 2026 ("Announces Dedicated Purchase Order Financing").
  • While CEO participation (50% subscription) signals insider alignment, the capital raise size ($100k) is immaterial relative to typical market expectations for a company with reported monthly revenues exceeding $100k.
  • The financing addresses working capital constraints inherent in the CPG business model rather than solving a fundamental solvency crisis or enabling a transformative acquisition.
  • Stock price reaction has been muted historically following similar financings, as evidenced by the decline from $0.14 highs to current levels despite revenue growth announcements.
  • There is no evidence of strategic investor entry (e.g., Sprott, Lundin) that would qualify this as a Game Changer or Material Positive event under analyst definitions.
HEAL · Price
Company Overview
  • Core Business: Restart Life Sciences operates as a health and wellness platform focusing on functional foods and consumer packaged goods (CPG).
  • Flagship Asset: Holy Crap Foods Inc., acquired in February 2026 for $1 million cash, serves as the primary revenue generator.
  • Product Portfolio: Includes gut health/digestive wellness products (Superseed, Oatmeal Variety Pack) and cognitive health lines (BrainQ, BrainBalls).
  • Recent Developments: In May 2026, the company announced a zero-upfront-cost licensing agreement for an additional health brand IP with royalty-based payment terms.
  • Manufacturing: Operates from a leased facility in Gibsons, BC, acquired as part of the Holy Crap deal, providing turnkey production capacity.
Read the original news release →

More from Restart Life Sciences Corp.

Jun 18, 2026 · 06:01

Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods

Production / Operations Jun 10, 2026 · 08:01

Restart Life Subsidiary Holy Crap Foods Marks New International Expansion Milestone with Bahamas On-Demand App Launch

Production / Operations Jun 03, 2026 · 06:01

Restart Life Sciences Taps CFO to Steer Holy Crap Foods' North American Expansion and Omnichannel Push

M&A / Property May 15, 2026 · 16:00

Restart Life Sciences Advances New Product Relaunch Utilizing Acquired Intellectual Property Portfolio

Production / Operations May 13, 2026 · 06:01

Restart Life Sciences Expands U.S. Footprint via Amazon Logistics Amidst Modest Revenue Growth and Capital Dilution

Other May 08, 2026 · 10:31

Restart Life Sciences Corp.

Financings